CAR-T cells and cancer nanovaccines: Comparative insights into advances and translational challenges
Open Access
- 1 June 2026
- journal article
- review article
- Published by Elsevier in Biotechnology Advances
- Vol. 91, 108942
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2024/02915-0)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2024/00989-7)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2024/20799-8)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (440398/2022-3)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (442690/2020-7)
This publication has 183 references indexed in Scilit:
- Fusion Peptide‐Incorporated Lipid Nanoparticles Boost Endosomal Escape and Enhance Cytosolic mRNA DeliveryAdvanced Materials, 2026
- Process Systems Engineering in Precision Medicine: Opportunities in Autologous CAR‐T TherapyEngineering in Life Sciences, 2026
- Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challengesMedcomm, 2024
- Circular RNA‐based neoantigen vaccine for hepatocellular carcinoma immunotherapyMedcomm, 2024
- Optimizing Lipid Nanoparticles for Delivery in PrimatesAdvanced Materials, 2023
- Role of tumor microenvironment in cancer progression and therapeutic strategyCancer Medicine, 2023
- Nanovaccines for cancer immunotherapyWIREs Nanomedicine and Nanobiotechnology, 2019
- An introduction to chimeric antigen receptor (CAR) T‐cell immunotherapy for human cancerAmerican Journal of Hematology, 2019
- Emerging Nano‐/Microapproaches for Cancer ImmunotherapyAdvanced Science, 2019
- Erythrocyte‐Membrane‐Enveloped Perfluorocarbon as Nanoscale Artificial Red Blood Cells to Relieve Tumor Hypoxia and Enhance Cancer RadiotherapyAdvanced Materials, 2017